By Henry Odeh
For the purpose of clinical trial treatment of COVID-19 otherwise called coronavirus, the National Agency for Food and Drug Administration and Control (NAFDAC) has approved and ordered the production of Chloroquine.
The director-general of NAFDAC, Mojisola Adeyeye, on Monday, March 3, said that the health agency took the decision following the use of the anti-malarial pill in many other countries, Channels TV reports.
Adeyeye revealed that nations like the United States (US) and France which have applied Chloroquine France for the clinical trial treatment of the disease have given testimonies of its effectiveness. She pointed out that the use of the drug in Nigeria will begin from Lagos state to evaluate the efficacy.
Coronavirus: Presidency gives update on Abba Kyari’s health status However, NAFDAC’s boss warned Nigerians to refrain from abusing the drug, adding that it has gastrointestinal upset, blurred vision, headache and itching as some of its side-effects.